Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Pierre Morel

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Nature Communications|July 11, 2020
Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolutionRoxane M Pommier, Amélien Sanlaville, Laurie Tonon, et al.
Oncoimmunology|May 4, 2016
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavageColette Dezutter-Dambuyant, Isabelle Durand, Laurent Alberti, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 9, 2023
Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer SubtypesAngèle Coutant, Vincent Cockenpot, Lauriane Muller, et al.
Cancer Research|November 26, 2020
EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast CancersMélanie K Prodhomme, Roxane M Pommier, Camille Franchet, et al.
Cancer Cell|July 5, 2008
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescenceStéphane Ansieau, Jeremy Bastid, Agnès Doreau, et al.
Plos Genetics|June 2, 2012
EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic miceAnne-Pierre Morel, George W Hinkal, Clémence Thomas, et al.
Communications Biology|October 7, 2022
SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4Adrien Bertrand-Chapel, Cassandre Caligaris, Tanguy Fenouil, et al.
Cancer Cell|September 14, 2013
p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancerVirginie Marcel, Sandra E Ghayad, Stéphane Belin, et al.
NAR Cancer|January 29, 2025
Specific modulation of 28S_Um2402 rRNA 2'-<i>O</i>-ribose methylation as a novel epitranscriptomic marker of ZEB1-induced epithelial-mesenchymal transition in different mammary cell contextsChloé Morin, Hermes Paraqindes, Flora Nguyen Van Long, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2024
Intricate ribosome composition and translational reprogramming in epithelial-mesenchymal transitionChloé Morin, Agnès Baudin-Baillieu, Flora Nguyen Van Long, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Nature Communications|July 11, 2020
Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolutionRoxane M Pommier, Amélien Sanlaville, Laurie Tonon, et al.
Oncoimmunology|May 4, 2016
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavageColette Dezutter-Dambuyant, Isabelle Durand, Laurent Alberti, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 9, 2023
Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer SubtypesAngèle Coutant, Vincent Cockenpot, Lauriane Muller, et al.
Cancer Research|November 26, 2020
EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast CancersMélanie K Prodhomme, Roxane M Pommier, Camille Franchet, et al.
Cancer Cell|July 5, 2008
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescenceStéphane Ansieau, Jeremy Bastid, Agnès Doreau, et al.
Plos Genetics|June 2, 2012
EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic miceAnne-Pierre Morel, George W Hinkal, Clémence Thomas, et al.
Communications Biology|October 7, 2022
SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4Adrien Bertrand-Chapel, Cassandre Caligaris, Tanguy Fenouil, et al.
Cancer Cell|September 14, 2013
p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancerVirginie Marcel, Sandra E Ghayad, Stéphane Belin, et al.
NAR Cancer|January 29, 2025
Specific modulation of 28S_Um2402 rRNA 2'-<i>O</i>-ribose methylation as a novel epitranscriptomic marker of ZEB1-induced epithelial-mesenchymal transition in different mammary cell contextsChloé Morin, Hermes Paraqindes, Flora Nguyen Van Long, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2024
Intricate ribosome composition and translational reprogramming in epithelial-mesenchymal transitionChloé Morin, Agnès Baudin-Baillieu, Flora Nguyen Van Long, et al.
Pageof 4